Article

Gut Metatranscriptomics Based De Novo Assembly Reveals Microbial Signatures Predicting Immunotherapy outcomes in Non-Small Cell Lung Cancer

2024-06-12

Abstract excerpt

<title>Abstract</title> <p>Background: Advanced-stage non-small cell lung cancer (NSCLC), presents significant treatment challenges, with immune checkpoint inhibitor (ICI) combinations being the primary therapeutic option. Emerging evidence highlights the gut microbiome's pivotal role in modulating the efficacy of such immunotherapies. Our study aims to elucidate the association between the gut microbiome and ICI...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 761927c0-69a3-5de3-95b1-15cf04c34ce8
DOI: 10.21203/rs.3.rs-4122044/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Gut Metatranscriptomics Based De Novo Assembly Reveals Microbial Signatures Predicting Immunotherapy outcomes in Non-Small Cell Lung CancerDOI 10.21203/rs.3.rs-4122044/v1Read

Distinct Functional Metagenomic Markers Predict the Responsiveness to Anti-PD-1 Therapy in Chinese Non-Small Cell Lung Cancer PatientsSemantic proximity Read

Distinct gut virome profiles are associated with response to anti-PD-1 therapy in non-small cell lung cancerSemantic proximity Read

Exploring Gut Microbiome in Predicting the Efficacy of Immunotherapy in Non-Small Cell Lung CancerSemantic proximity Read

Gut microbial signature in lung cancer patients highlights specific taxa as predictors for durable clinical benefitSemantic proximity Read

Leveraging circulating microbiome signatures to predict tumor immune microenvironment and prognosis of patients with non-small cell lung cancerSemantic proximity Read

Gut microbiome metabolites, molecular mimicry, and species-level variation drive long-term efficacy and adverse event outcomes in lung cancer survivorsSemantic proximity Read

The characteristics of intratumoral microbial community reflect the development of lung adenocarcinomaSemantic proximity Read

Metagenomic and Metabolomic Correlates of Immunotherapy Response in Non-Small Cell Lung CancerSemantic proximity Read

Metatranscriptomic Analysis of Human Lung Metagenomes from Patients with Lung Cancer.Semantic proximity Read

Leveraging circulating microbiome signatures to predict tumor immune microenvironment and prognosis of patients with non-small cell lung cancerSemantic proximity Read

Microbial Determinants of Immune Activation and Clinical Outcome in Lung Tumor SubtypesSemantic proximity Read

Gut Microbiota Signatures with Potential Clinical Usefulness in Colorectal and Non-small Cell Lung CancersSemantic proximity Read